Tesla (NASDAQ: TSLA) announced it will start production of its long-delayed Semi trucks by the end of 2025 at its Nevada gigafactory. In a video posted to YouTube, Tesla revealed it is building a new Semi production line at the site, with a planned annual capacity of 50,000 units. High-volume production is expected to ramp up through 2026.
Dan Priestley, head of the Semi program, confirmed that the first trucks will roll off the line later this year. Tesla originally unveiled the Semi in 2017 and had produced a limited batch before halting production in 2022. CEO Elon Musk had previously targeted producing 50,000 Semis in 2024, a goal that was not met.
Despite the delays, Tesla has delivered at least 50 Semi trucks to Pepsi, which is incorporating them into its U.S. fleet. The Semi project marks a strategic move by Tesla to diversify beyond its core electric vehicle business, which is grappling with slowing sales and boycotts in the U.S. and Europe linked to Musk’s political views.
Tesla also faces new challenges from rising trade tensions, particularly with steep tariffs imposed by U.S. President Donald Trump on Chinese imports, potentially raising parts costs. Adding to the uncertainty, Tesla recently withdrew its 2025 growth forecast, citing economic instability and escalating U.S.-China trade disputes, with plans to reassess its targets in three months.


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



